Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650714 · ClinicalTrials.gov registry record · NA
Endoscopic Full Thickness Biopsy, Gastric Wall.
A NA study of Gastroparesis, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT01650714: Completed NA study of Gastroparesis, sponsored by Mayo Clinic.
NCT01650714 is a NA study of Gastroparesis that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01650714, a NA study of Gastroparesis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will assess the efficacy and safety of the innovative endoscopic technique for the acquisition of full thickness gastric muscle wall biopsies. Having access to full thickness biopsies will allow an increased understanding of the pathophysiology of gastrointestinal diseases such as functional gastrointestinal disorders, gastroparesis, pseudoobstruction and other motility disorders. This information is essential to development of more targeted and effective therapy than currently available. Despite the high prevalence of functional gastrointestinal disorders and its significant impact on social and health care costs, the underlying cause is not well understood and there is no effective specific treatment to successfully alleviate patient symptoms.
Primary Outcome
Success of the endoscopic resection will be defined by efficacy and safety: 1) Efficacy is defined as obtaining a full thickness resection and 2) Safety is defined as the absence of serious adverse events.
Conditions Studied
Interventions
- OTHER Full thickness gastric biopsy
- PROCEDURE Full thickness gastric biopsy
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01650714 record still lists
NCT01650714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which Full thickness gastric biopsy is the first listed.
NCT01650714 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01650714 about?
NCT01650714 is a clinical study titled "Endoscopic Full Thickness Biopsy, Gastric Wall.". The proposed study will assess the efficacy and safety of the innovative endoscopic technique for the acquisition of full thickness gastric muscle wall biopsies. Having access to full thickness biopsies will allow an increased understanding of the pathophysiology of gastrointestinal diseases such as...
What is the current status of trial NCT01650714?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2012-09. Estimated completion is 2014-09.
What conditions does trial NCT01650714 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT01650714?
The interventions under investigation include: Full thickness gastric biopsy (OTHER), Full thickness gastric biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01650714?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01650714 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01650714's enrollment target sits among peer trials
3 45th of 44 the lowest of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia